Literature DB >> 10370885

[Study of the relationships between self-injurious behavior and pain reactivity in infantile autism].

S Tordjman1, C Antoine, D J Cohen, A Gauvain-Piquard, M Carlier, P Roubertoux, P Ferrari.   

Abstract

Autism can be considered as an early general developmental disorder, characterized by problems of social interaction, problems of verbal and non verbal communication, and behavioral or ideational stereotypes. However, within autism we observe a clinical heterogeneity of autistic disorders which suggests the possibility of autistic subtypes. Several authors hypothesize an analgesia among autistic children; this analgesia may be related to self-mutilation found among autistics. The current research had two objectives: 1) to develop and validate evaluation tools for measuring aggression directed towards the self (Yale-Paris Self-Injurious Behavior Scale: YAPA SIB) and pain reactivity (Pre-Linguistic Behavioral Pain Reactivity Scale: PLBPRS); instruments appropriate for autistics and capable of showing different behavioral sub-types; 2) to study in 80 autistic children pain reactivity, self-injurious behavior, and their relation in different observational situations. The results show that the scales of self-injurious behavior and pain reactivity have good discriminative capacity, good test-retest reliability, and good validity. The results suggest additionally that the apparent decreased pain reactivity observed in autistics does not derive from a real analgesia but from a different mode of pain expression related to difficulties with verbal communication, body representation and certain cognitive disorders (learning disorders, problems representing sensations and emotions, problems establishing cause-effect relationships). Additionally, there is a significant relationship between certain self-injurious behaviors and the apparent reduced pain reactivity. Interpretations of this result are presented and the possible role of stress in autism is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10370885

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  8 in total

Review 1.  [Autism and pain - a literature review].

Authors:  Amandine Dubois; Cécile Rattaz; René Pry; Amaria Baghdadli
Journal:  Pain Res Manag       Date:  2010 Jul-Aug       Impact factor: 3.037

2.  Self injurious behavior in autism: clinical aspects and treatment with risperidone.

Authors:  R Canitano
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

3.  Sensory Processing in Low-Functioning Adults with Autism Spectrum Disorder: Distinct Sensory Profiles and Their Relationships with Behavioral Dysfunction.

Authors:  Corentin Gonthier; Lucie Longuépée; Martine Bouvard
Journal:  J Autism Dev Disord       Date:  2016-09

Review 4.  Pain sensitivity and observer perception of pain in individuals with autistic spectrum disorder.

Authors:  C S Allely
Journal:  ScientificWorldJournal       Date:  2013-06-13

5.  Aggression in low functioning children and adolescents with autistic disorder.

Authors:  Guillaume Bronsard; Michel Botbol; Sylvie Tordjman
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

6.  Sensitivity to Pain in Children With Acute Lymphoblastic Leukemia (ALL).

Authors:  Manijeh Firoozi; Reza Rostami
Journal:  Iran J Cancer Prev       Date:  2012

Review 7.  The Current View on the Paradox of Pain in Autism Spectrum Disorders.

Authors:  Olena V Bogdanova; Volodymyr B Bogdanov; Adrien Pizano; Manuel Bouvard; Jean-Rene Cazalets; Nicholas Mellen; Anouck Amestoy
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

8.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.